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ITAM-Based Interaction of ERM Proteins
with Syk Mediates Signaling
by the Leukocyte Adhesion Receptor PSGL-1
(Alon et al., 1996, 1997). The selectin family includes
three membrane glycoproteins that display different pat-
terns of expression and function. L-selectin is constitu-
tively expressed by the majority of circulating leukocytes
and is implicated in homing and leukocyte recruit-
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et al., 2000; Norman et al., 2000; Xia et al., 2002); how-
ever, there is no evidence that PSGL-1 is a ligand for
P-selectin glycoprotein ligand 1 (PSGL-1) is a leuko-
L-selectin in vivo.cyte adhesion molecule involved in cell tether and roll-
Besides its interaction with selectins, PSGL-1 alsoing on activated endothelium. Our work shows that
seems to have a role as a signal-transducing molecule.PSGL-1 associates with Syk. This association is medi-
In this regard, it has been reported that the cytoplasmicated by the actin-linking proteins moesin and ezrin,
tail of PSGL-1 interacts with ezrin and moesin (Alonso-which directly interact with Syk in an ITAM-dependent
Lebrero et al., 2000). Proteins of the ezrin/radixin/moesinmanner. PSGL-1 engagement induces tyrosine phos-
(ERM) family function as membrane-actin cytoskeletonphorylation of Syk and SRE-dependent transcriptional
linkers (Mangeat et al., 1999) and play a key role in theactivity. Treatment of cells with the Syk inhibitor pice-
formation of protrusive plasma membrane structuresatannol and overexpression of either a Syk dead ki-
such as filopodia, microspikes, or microvilli (Bretschernase mutant or an ITAM-mutated moesin abrogated
et al., 2000; Vaheri et al., 1997; Yonemura and Tsukita,PSGL-1-induced transcriptional activation. These data
1999). PSGL-1 is also a potent negative regulator ofunveil a new functional role for the ERMs (ezrin/ra-
human hematopoietic progenitor cells (Levesque et al.,dixin/moesin) as adaptor molecules in the interactions
1999). Furthermore, the engagement of PSGL-1 inducesof adhesion receptors and intracellular tyrosine ki-
tyrosine phosphorylation and activation of MAP kinasesnases and show that PSGL-1 is a signaling molecule
in human neutrophils (Hidari et al., 1997), as well asin leukocytes.
cytokine release by neutrophils, monocytes, and T cells
(Celi et al., 1994; Damle et al., 1992; Weyrich et al., 1995,Introduction
1996) and activation of 2 integrin binding to ICAM-1
(Simon et al., 2000). However, the molecular mechanismRecruitment of leukocytes to inflammatory foci is a
which links PSGL-1 engagement and the subsequentmultistep process initiated by their interaction with the
intracellular signaling cascades remain unknown. In thisselectins expressed on activated endothelial cells,
paper, we report that PSGL-1 associates with Sykwhich mediate the rolling of leukocytes on endothelium
through its interaction with moesin and that the engage-(Kansas, 1996; McEver et al., 1995; Vestweber and
ment of PSGL-1 promotes tyrosine phosphorylation ofBlanks, 1999). Selectins possess unique biophysical and
molecular properties that account for their ability to me- Syk and transcriptional activation of SRE element and
diate the transient tethering and rolling of leukocytes c-fos promoter and gene expression. These data under-
line the importance of ERM proteins in connecting leuko-
cyte adhesion receptors and tyrosine kinases.6 Correspondence: fsanchez@hlpr.insalud.es
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Figure 1. Association of PSGL-1 and Syk
(A) GST or the cytoplasmic tail of PSGL-1 fused to GST (GST-PSGL-1) was bound to glutathione-Sepharose beads and incubated with 35S-
Met-labeled proteins from HL-60 cell lysates. The proteins pulled down were analyzed by SDS/PAGE (left). A protein band of 70 kDa (arrow)
was digested with trypsin and analyzed by mass spectrometry (right). The peptides corresponding to the human tyrosine kinase Syk are
labeled with a black triangle.
(B and C) Western blot analyses with specific anti-Syk mAb (4D10.1) of proteins pulled down from HL-60 cell lysates with the cytoplasmic
tail of PSGL-1 fused to GST (GST-PSGL-1) bound to glutathione-Sepharose beads (B) or with PL2 specific anti-PSGL-1 mAb (C). Sepharose-
glycine was used as control in (C).
(D) Amino acid sequences of the wild-type (wt) and several deletions of the cytoplasmic tail of PSGL-1.
(E) GST or the GST-fusion proteins containing the wt or the deletion mutants of the cytoplasmic tail of PSGL-1 were bound to glutathione-
Sepharose beads and incubated with HL-60 cell extracts. The proteins pulled down were analyzed by Western blot with anti-moesin- or anti-
Syk-specific antibodies. The relative binding capabilities of moesin and Syk to GST-cytoplasmic deletions of PSGL-1 were estimated by
densitometric analysis comparing the amount of moesin and Syk bound to equal amounts of each fusion protein with the amount eluted from
GST-PSGL-1 wild-type, as described previously by Yonemura et al., (1998). Values correspond to the arithmetic mean SE of three independent
experiments.
Results PSGL-1 required for Syk association, protein deletion
mutants of the PSGL-1 cytoplasmic domain were fused
to GST (Figure 1D) and incubated with HL-60 cell lysates.Syk Associates with the Cytoplasmic Domain
of PSGL-1 Proteins pulled down with the different GST-PSGL-1
constructs were resolved by SDS-PAGE and analyzedTo search for intracellular proteins that associate with
PSGL-1, we incubated 35S-Met-labeled HL-60 cell ly- by Western blot using anti-Syk and anti-moesin antibod-
ies. As shown in Figure 1E, a juxtamembrane regionsates with a chimeric protein containing the cytoplasmic
tail of PSGL-1 fused to GST. Several proteins specifically of 18 amino acids of the PSGL-1 cytoplasmic tail was
accounting for the association with Syk, which was coin-bound to the cytoplasmic domain of PSGL-1 (Figure
1A). Two of them, with apparent Mr of 78 and 85 kDa, cident with the PSGL-1 binding region to moesin (Serra-
dor et al., 2002a).corresponded to moesin and ezrin (Alonso-Lebrero et
al., 2000). A new protein band of 70 kDa was subse-
quently processed by in situ digestion with trypsin and Colocalization of SYK and PSGL-1 in Lymphoid Cells
To assess the subcellular localization of PSGL-1 andanalyzed by mass spectrometry. A database search
yielded a clear match with Syk (Figure 1A). The associa- Syk, immunofluorescence experiments were carried out
in different cells. The polarized mouse myeloma cell linetion of Syk to PSGL-1 was verified by Western blot
(Figure 1B). Furthermore, this interaction was confirmed NS1 was cotransfected with a cDNA construct con-
taining human PSGL-1 fused to GFP and an expressionby coimmunoprecipitation of Syk with PSGL-1 in HL-60
cells (Figure 1C). plasmid containing the human Syk full-length cDNA. As
shown in Figure 2A, PSGL-1 was concentrated in theTo determine the minimal cytoplasmic sequence of
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Figure 2. Colocalization of PSGL-1 and Syk in Lymphoid Cells
(A) NS1 cells were transiently cotransfected with PSGL-1-GFP and Syk cDNAs, grown on glass coverslips for 24 hr, fixed, and stained for
Syk (red) with a polyclonal anti-Syk antibody. The subcellular distribution of PSGL-1 and Syk was analyzed by fluorescence microscopy. The
corresponding differential interference contrast (DIC) image of the cell is shown.
(B) Human T lymphoblasts were double stained for PSGL-1 (green) and Syk (red), and their subcellular distribution was analyzed by fluorescence
microscopy. The DIC image of cells is shown.
(C) Human T lymphoblasts were double stained for PSGL-1 and Syk and analyzed by confocal microscopy. In order to show the whole signal,
a projection of the complete stack of confocal sections is depicted. Lower panels show an orthogonal section of the site of the uropod
indicated by the arrow. The position of the cell is indicated in the differential interference contrast.
cell uropod, while Syk was located at both the uropod Moesin Acts as an Adaptor Protein
in PSGL-1-Syk Interactionand cell leading edge. The distribution of endogenous
PSGL-1 and Syk was also analyzed in T lymphocytes. To investigate whether the association of PSGL-1 with
Syk took place through a direct interaction, 35S-Met-SykIn these cells, PSGL-1 was concentrated at the cellular
uropod, and Syk was located at both cell poles (Figure was incubated with the cytoplasmic domain of PSGL-1
fused to GST. We did not find any direct interaction2B). Confocal analysis of the endogenous distribution
of both molecules in T cells confirmed their colocaliza- between both proteins (Figure 3B). Since ERM proteins
contain an ITAM-like motif in their amino-terminal regiontion at the trailing edge of polarized migrating cells (Fig-
ure 2C). (Figure 3A, and Rozsnyay et al., 1996), it was of interest
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to examine whether Syk and moesin could directly inter- the tyrosine phosphorylation level of Syk was clearly
increased upon anti-PSGL-1 engagement, both in lym-act. Figure 3B shows that Syk bound to the full-length
as well as to the amino-terminal region of moesin phocytes and U937 cells (Figures 4A and 4B). In contrast,
no significant tyrosine phosphorylation of Syk was in-(N-moesin) but failed to interact with the carboxy-termi-
nal region of the protein (C-moesin), suggesting that this duced by engagement of HLA-A, B, or CD7, which were
used as controls (Figure 4A). As shown in Figure 4B,interaction could take place through the ITAM-like motif
of moesin. In addition, Syk also bound to ezrin (full- piceatannol, which at low concentrations has been
shown to selectively inhibit the activation of Syk as com-length and amino-terminal region), indicating that Syk
interacts with other members of the ERM family (Fig- pared to the Src family kinases (Oliver et al., 1994), pre-
vented the induction of Syk tyrosine phosphorylation byure 3C).
Then, we tested whether moesin could act as an adap- PSGL-1 engagement with either of the two specific anti-
PSGL-1 mAbs used. To study whether Syk was alsotor molecule in Syk/PSGL-1 interaction. Protein binding
assays with GST-PSGL-1 fusion protein bound to glu- activated by interaction of PSGL-1 with P-selectin, U937
cells were incubated, under rotating conditions, at 37Ctathion-Sepharose beads, 35S-Met-labeled Syk, and
N-moesin demonstrated that PSGL-1 only interacted for 10 min on a monolayer of CHO cells stably expressing
P-selectin. As shown in Figure 4C, the level of tyrosinewith Syk in the presence of N-moesin, indicating that
moesin is able to link PSGL-1 and Syk (Figure 3D). To phosphorylation of Syk was significantly increased upon
the interaction of U937 cells with P-selectin-CHO cells,address the possible role of the ITAM-like motif of moe-
sin in its interaction with Syk, the two tyrosines of this compared with untransfected CHO cells. Likewise, a
similar induction of Syk phosphorylation was observedmotif were mutated to phenylalanine (Y191FY205F)
(Figure 3A). Protein binding assays showed that the upon interaction of U937 cells with CHO cells stably
transfected with E-selectin (Figure 4C).Y191FY205F moesin mutant had completely lost the
ability to associate with Syk (Figure 3E), demonstrating
the key role of the moesin ITAM-like motif in the Syk- PSGL-1 Engagement Induces SRE-Dependent
moesin interaction. Transcriptional Activation
Moesin has been already reported to be tyrosine To assess whether the engagement of PSGL-1 was able
phosphorylated (Meyer et al., 1998). We next assessed to induce gene transcriptional activation, U937 cells
whether the reticulocyte lysate had the ability to phos- were transfected with different reporter plasmids where
phorylate bacterially produced moesin in tyrosine. As luciferase expression is driven by multimers of the SRE
shown in Figure 3F, moesin was tyrosine phosphory- or NFB consensus sequences. Remarkably, the SRE-
lated when the reticulocyte lysate was added, and the dependent transcriptional activity was clearly induced
level of phosphorylation increased when Syk was pre- in cells treated with an anti-PSGL-1 mAb antibody (Fig-
viously translated by the reticulocyte lysate. ure 5A). In contrast, no significant induction was ob-
served with control antibodies (Figure 5A). In addition,
as shown in Figure 5B, the SRE transcriptional activityPSGL-1 Engagement Induces Tyrosine
Phosphorylation of Syk was significantly higher in U937 cells interacting with
either P- or E-selectin, compared to a control protein,The possible involvement of Syk in the signaling trig-
gered through PSGL-1 was assessed. First, Syk tyrosine indicating that the interaction of PSGL-1 with P- or
E-selectin was also able to induce gene transcriptionalphosphorylation was analyzed after PSGL-1 engage-
ment as an indicator of Syk activation. We found that activation. Experiments in parallel evidenced that NFB
Figure 3. Interaction of Syk with Moesin and Ezrin
(A) Consensus sequence for the ITAM motif and amino acid sequences found in the amino-terminal domains of the different proteins of the
ERM family (the ITAM motif is underlined in each sequence). The amino acid sequence for the moesin mutant in which tyrosines 191 and 205
have been substituted by phenylalanine is also shown.
(B) GST and GST-fusion proteins containing the wt cytoplamic tail of PSGL-1, the full-length sequence of moesin, the amino-terminal domain
of moesin (N-moesin), or the carboxy-terminal domain of moesin (C-moesin) were bound to Sepharose beads and incubated with 35S-Met-
labeled Syk obtained by a transcription and translation-coupled system. After incubation, beads were centrifuged, washed, and boiled in
sample buffer, and eluted proteins were analyzed by SDS-PAGE and autoradiography. A representative experiment is shown. Relative binding
of Syk to GST-fusion proteins was estimated by densitometric analysis.
(C) GST or GST-fusion proteins containing the full-length sequence of ezrin or the amino-terminal domain of ezrin (N-ezrin) were bound to
Sepharose beads and incubated with 35S-Met-labeled in vitro-translated Syk. The autoradiography and Coomassie blue staining of GST and
GST-fusion proteins used are shown.
(D) GST and GST-PSGL-1 fusion proteins containing the wt cytoplasmic tail or the deletion mutant containing the 18-juxtamembrane amino
acids of PSGL-1 were bound to Sepharose beads and incubated with 35S-Met-labeled in vitro-translated Syk, in the presence or absence of
N-moesin. The proteins eluted from the beads were analyzed by SDS/PAGE. The autoradiography, Coomassie blue staining of the fusion
proteins used, and the relative binding of Syk to the fusion proteins are shown.
(E) GST or GST-fusion proteins containing the wild-type full-length sequence of moesin, the ITAM-mutated moesin (Y195FY205F), the amino-
terminal domain of moesin (N-moesin), or the carboxy-terminal domain of moesin (C-moesin) were bound to Sepharose beads and incubated
with 35S-Met-labeled in vitro-translated Syk. The autoradiography, the Coomassie blue staining of GST and GST-fusion proteins used, and
the relative binding of Syk to GST-fusion proteins, estimated by densitometry, are shown.
(F) GST and GST-moesin full-length fusion protein bound to Sepharose beads were incubated for 3 hr at 4C with reticulocyte lysates control
or containing Syk previously translated. Then, beads were washed and analyzed by Western blot with anti-phospho-tyrosine (anti-P-Tyr) mAb.
The relative level of phosphorylation of the GST-moesin fusion proteins and GST has been calculated by densitometric analysis.
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Figure 4. PSGL-1 Engagement Induces Tyrosine Phosphorylation of Syk
(A) T lymphoblasts were incubated at 37C for 10 min with 10 g/ml of anti-PSGL-1 (PL1), anti-HLA-A, B (W6/32), or anti-CD7 (3A1) mAbs.
After treatment, cells were lysed and Syk was immunoprecipitated and analyzed by Western blot with anti-P-Tyr or anti-Syk mAbs.
(B) U937 cells were incubated at 37C for 30 min in the presence or absence of 25 M piceatannol and then for 10 min with anti-PSGL-1 (PL1
or KPL1) mAb. Syk was immunoprecipitated from lysates of treated cells and analyzed by Western blot with anti-P-Tyr or anti-Syk antibodies.
(C) U937 cells were incubated, under rotating conditions, at 37C for 10 min on monolayers of control CHO cells or CHO cells stably transfected
with P- or E-selectin. Nonadherent cells were harvested, and Syk was immunoprecipitated from the cell lysates and analyzed by Western blot
with anti-P-Tyr or anti-Syk antibodies.
was barely activated, in agreement with previous results scriptional activation by PSGL-1, while overexpression
of wt Syk increased both the basal and the PSGL-1-(Figure 5A and Weyrich et al., 1995). Since c-fos is a
gene whose expression is highly dependent on SRE induced activation of SRE (Figure 6B). These results
demonstrated that Syk is involved in the PSGL-1-medi-(Treisman, 1995), we tested whether PSGL-1 engage-
ment resulted in the activation of the c-fos promoter. ated signals that regulate induction of gene tran-
scription.As expected, treatment of cells with an anti-PSGL-1
mAb antibody but not with a control antibody resulted in Finally, we decided to investigate the relevance of
the moesin-Syk interaction in the signaling triggered bythe transcriptional activation of both the c-fos promoter
and the endogenous c-fos gene (Figures 5C and 5D, PSGL-1. Overexpression in U937 cells of the moesin
mutant Y191FY205F, which is unable to bind Syk, re-respectively).
sulted in the inhibition of PSGL-1-induced SRE activa-
tion (Figure 6C). Moreover, overexpression of the wild-Transcriptional Activation Induced by PSGL-1 Is
type moesin clearly increased both the basal and theMediated through the Moesin-Syk Complex
PSGL-1-induced SRE transactivation. These results in-To ascertain whether Syk was directly implicated in the
dicated that moesin, by coupling PSGL-1 and Syk, actstranscriptional activation induced through PSGL-1, U937
as a key adaptor molecule in the signaling pathwaycells were pretreated with piceatannol before PSGL-1
triggered by PSGL-1.engagement. A low concentration of this inhibitor was
able to abolish the PSGL-1-mediated transcriptional ac-
tivation of SRE and the endogenous c-fos gene ex- Discussion
pression (Figures 6A and 5D, respectively). Like-
wise, overexpression of a kinase dead mutant of Syk There is evidence for a role of PSGL-1 as a signal trans-
mitting receptor in different cell types including neutro-(Y518FY519F) was also able to prevent the SRE tran-
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Figure 5. PSGL-1 Engagement Induces SRE-Dependent Transcriptional Activation
(A) U937 cells were transfected with luciferase reporter plasmids driven by NFB or SRE multimers. Transfected cells were incubated at 37C
for 6 hr without antibody or with 10 g/ml of anti-PSGL-1 (PL1), anti-HLA-A, B (W6/32), or anti-CD7 (3A1) mAbs. The data shown (fold induction
of luciferase activity over the basal of the nontreated cells) represent mean  SD of three independent experiments. All the Firefly luciferase
values were corrected for the Renilla luciferase values obtained in each case.
(B) U937 cells were transfected with the SRE-luciferase reporter construct and incubated, at 37C for 6 hr, on plates coated with P-selectin,
E-selectin, or BSA. Then, cells were lysed and analyzed for luciferase activity. The data shown (fold induction of luciferase activity over the
basal of the nontreated cells) represent mean  SD of three independent experiments. All the Firefly luciferase values were corrected for the
Renilla luciferase values obtained in each case.
(C) U937 cells (2  105) transfected with the c-fos-luciferase reporter construct were incubated for 6 hr without antibody or with 10 g/ml of
anti-PSGL-1 (PL1) or anti-HLA-A, B (W6/32) mAbs. Then, cells were lysed and analyzed for luciferase activity. The data shown (fold induction
of luciferase activity over the basal of the nontreated cells) represent mean  SD of three independent experiments. All the Firefly luciferase
values were corrected for the Renilla luciferase values obtained in each case.
(D) U937 cells (107 cells/ml) were incubated at 37C for the indicated times with 10 g/ml of anti-PSGL-1 (KPL1) or without antibody and then
lysed and analyzed by RT/PCR for the expression of endogenous c-fos and -actin genes (left panel). In the right panel, U937 cells (107 cells/
ml), pretreated or not for 30 min at 37C with 25 M piceatannol, were incubated at 37C for 30 min with 10 g/ml of anti-PSGL-1 (KPL1) or
anti-HLA-A,B (W6/32) antibodies, or without antibody. Then cells were lysed and analyzed by RT/PCR for c-fos and -actin expression. The
basal expression of c-fos and -actin genes in untreated cells is also shown in the right panel (C).
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Figure 6. Transcriptional Activation Promoted by PSGL-1 Is Mediated by Syk and Moesin
(A) U937 cells were transfected with SRE-luciferase reporter construct. After 30 min of incubation at 37C in the presence or absence of 6
M piceatannol, 2  105 cells were incubated for 6 hr without antibody or with 10 g/ml of anti-PSGL-1 (PL1), anti-HLA-A, B (W6/32), or anti-
CD7 (3A1) mAbs. Then, cells were lysed and analyzed for luciferase activity. A representative experiment out of three independent ones is
shown. Bars represent mean  SD of triplicate samples. All the Firefly luciferase values were corrected for the Renilla luciferase values
obtained in each case.
(B) U937 cells were transfected with empty pME18S plasmid or with the same vector expressing wt Syk or a kinase dead mutant Syk
(Y518FY519F), in the presence of SRE-luciferase reporter construct. Transfected cells (2  105) were then incubated for 6 hr without antibody
or with 10 g/ml of anti-PSGL-1 (PL1) or anti-HLA-A, B (W6/32) mAbs. After treatment, cells were lysed and analyzed for luciferase activity.
A representative experiment out of three is shown. Bars represent mean  SD of triplicate samples. All the Firefly luciferase values were
corrected for the Renilla luciferase values obtained in each case.
(C) U937 cells were transfected with empty pCR3 plasmid or with the same vector expressing wt moesin or the moesin mutant (Y191FY205F),
in the presence of SRE-luciferase reporter construct. Transfected cells (2  105) were then incubated for 6 hr without antibody or with 10 g/
ml of anti-PSGL-1 (PL1) or anti-HLA-A, B (W6/32) mAbs. After treatment, cells were lysed and analyzed for luciferase activity. A representative
experiment out of three independent ones is shown. Bars represent mean  SD of triplicate samples. All the Firefly luciferase values were
corrected for the Renilla luciferase values obtained in each case.
phils (Hidari et al., 1997), monocytes (Weyrich et al., able to transactivate the transcriptional activity of the
c-fos promoter activity, as well as the endogenous c-fos1995, 1996), T lymphocytes (Damle et al., 1992), and
human hematopoietic stem cells (Levesque et al., 1999). gene, which is highly dependent on SRE (Treisman,
1995).However, the mechanism by which PSGL-1 triggers
such signaling has not been elucidated so far. In this The transcriptional activation triggered by PSGL-1 re-
quires the participation of Syk, as evidenced by itsreport we provide evidence for the association of
PSGL-1 with Syk and demonstrate that this tyrosine blockade with piceatannol as well as by overexpression
of a dead kinase mutant of Syk. In addition, overexpres-kinase is activated upon engagement of PSGL-1 both in
lymphocytes and U937 cells. In addition, signals elicited sion of the wild-type Syk was able to activate both the
basal and the PSGL-1-dependent transcriptional activa-through PSGL-1 are able to induce expression of re-
porter plasmids driven by SRE, a finding consistent with tion. Thus, our data strongly suggest that the activation
of SRE through PSGL-1 requires the activation of thethe reported activation of Erk by PSGL-1 (Hidari et al.,
1997). Accordingly, we have also found that PSGL-1 is protein tyrosine kinase Syk, which we have found to be
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associated with PSGL-1. The weak activation of NFB Yonemura et al., 1998). These molecules colocalize and
interact with ERM proteins at the trailing edge of migra-upon PSGL-1 engagement is in agreement with a previ-
ous work which reported that a costimulus was needed tory lymphocytes (Serrador et al., 1997, 1998). Moreover,
the functional role of the interaction of moesin withfor the NFB activation induced through PSGL-1 (Wey-
rich et al., 1995). The induction of expression of early- ICAM-3 in the membrane targeting of this receptor at
the cell trailing edge during leukocyte migration hasimmediate activation genes upon PSGL-1 engagement,
such as c-fos, is a relevant finding for the endothelial- been recently reported (Serrador et al., 2002b) . On the
other hand, a recent work revealed that ICAM-3 has anleukocyte interaction that occurs during the extravasa-
tion process of leukocytes toward inflammatory foci. important role in the antigen scanning by T cells on
APCs. However, ICAM-3 is excluded from the center ofThus, during the rolling of leukocytes on activated endo-
the immunological synapse (IS) and is localized in thethelium, the interaction of PSGL-1 with selectins triggers
actin-rich cellular protrusions (Montoya et al., 2002).different signaling pathways that contribute to leukocyte
PSGL-1 and CD43 are also excluded from the region ofactivation. This phenomenon would also occur when
the immunological synapse, a phenomenon that, at leastleukocytes have been recruited to sites of inflammation,
in the case of CD43, is mediated by ERM proteins (Allen-by the interaction of PSGL-1 with the selectins ex-
spach et al., 2001; Delon et al., 2001; Montoya et al.,pressed on the surface of other leukocytes and platelets
2002). Nevertheless, ezrin appears to have a critical role(Alon et al., 1996; del Pozo et al., 1997; Patel et al., 1995;
in the formation of the IS, as deduced from the inhibitoryRainger et al., 1998). As in the case of PSGL-1, another
effect of the overexpression of a dominant-negativemucin leukocyte receptor, CD43, interacts with moesin
form of ezrin (N-ezrin) on the localization of the TCRand ezrin (Serrador et al., 1998; Yonemura et al., 1998).
at the central supramolecular antigen complex (SMAC)It has been reported that CD43 triggers a signaling path-
(Roumier et al., 2001). In this regard, our finding thatway mediated by Syk and that it induces the activation
ERM proteins bind Syk in an ITAM-dependent mannerof AP-1 and the expression of CD69 (Santana et al.,
suggests that ezrin could act as an scaffold protein2000; Tada et al., 1999). On the other hand, it has been
recruiting Syk, ZAP-70, and probably other intermediaterecently reported that Syk acts as a tumor suppressor
and effector molecules. Accordingly, our preliminary re-in human breast cancer cells (Coopman et al., 2000).
sults suggest that ZAP-70 is also able to associate toThis new functional role of Syk could be related to the
the ITAM motif of the ERMs (A.U., unpublished data).function of PSGL-1 as suppressor of hematopoiesis
The possible role of ERMs as scaffold proteins for mole-(Levesque et al., 1999).
cules of the TCR signaling complex in the IS wouldOur data indicate that PSGL-1 associates with Syk,
explain the inhibition of NFAT activation and IL-2 pro-but that this association is not direct and requires the
duction observed by overexpression of N-ezrin (Roumierpresence of moesin, which acts as an adaptor protein.
et al., 2001).Hence, we found that Syk directly binds to moesin and
Altogether, our results allow us to postulate that ERMezrin through the ITAM-like motif of the amino-terminal
proteins, in addition to their function as linkers of mem-domain of ERM proteins (Rozsnyay et al., 1996) and that
brane receptors with cytoskeleton (Mangeat et al., 1999;PSGL-1 associates with Syk through these proteins. The
Yonemura and Tsukita, 1999), play an important role asinteraction of PSGL-1 with moesin and ezrin has been
adaptor proteins in intracellular signaling cascades. Itpreviously reported (Alonso-Lebrero et al., 2000). Our
is very likely that this novel function of ERM proteins hasdata show that the indirect association of Syk to PSGL-1
a critical role in the outside-in signaling of cell adhesionis mediated through the juxtamembrane region of
receptors lacking kinase activity or ITAM motifs in theirPSGL-1, a domain that is necessary and sufficient for
cytoplasmic tails.moesin binding and that is responsible for its targeting
to the uropod of the cell (Serrador et al., 2002a). On the
Experimental Procedures
other hand, we have also found that the mutation of
the tyrosine residues of moesin ITAM abolishes both Cell Culture and Transfection
the Syk-moesin binding and the gene transactivation The human myeloid cell lines HL-60 and U937 were grown in RPMI
1640 medium supplemented with 10% of fetal bovine serum at 37Ctriggered by PSGL-1. Moesin can be phosphorylated in
in a humidified atmosphere with 5% CO2. The mouse myeloma NS1tyrosine, as shown in this work under our assay condi-
cell line was grown in complete medium with 50 M -mercaptoeth-tions and by others (Meyer et al., 1998). Therefore, it is
anol (Sigma Chemical Co., St Louis, MO). Human peripheral blood
feasible that in our binding assay conditions the moesin mononuclear cells (PBLs) were isolated from buffy coats over a
ITAM is phosphorylated, allowing a phosphotyrosine- Lymphoprep gradient (Nycomed Pharma AS, Oslo, Norway), and T
dependent mechanism of Syk interaction. Nevertheless, lymphoblasts were obtained by stimulation for 48 hr with 5 g/ml
of phytohemaglutinin (PHA) and then treated with human rIL-2the possibility cannot be ruled out that, as in the case
(R&D Systems, Minneapolis, MN) for 8 to 15 days. Chinese hamsterof Syk-3 integrin interaction (Gao et al., 1997; Wood-
ovary (CHO) cells expressing a stably transfected human E- orside et al., 2001), a phosphotyrosine-independent bind-
P-selectin cDNA and the parental cell line (CHO-DUKX) were grown
ing of Syk to moesin could also occur. Altogether, these as described previously (Montoya et al., 1999).
data indicate that ERM proteins act as adaptor mole- NS1 cells were transiently transfected and processed for immuno-
fluorescence as described (Serrador et al., 2002b). U937 cells werecules, allowing the coupling of PSGL-1 with Syk and thus
transfected by electroporation as described (Rubio et al., 1995) andthe subsequent transmission of the PSGL-1-dependent
then stimulated for 6 hr before being lysed for luciferase activitysignaling cascade.
determination.Several other adhesion receptors, such as ICAM-3,
ICAM-2, ICAM-1, L-Selectin, CD43, or CD44, have been Proteins and Antibodies
found to interact with proteins of the ERM family (Heiska Human P-selectin and E-selectin were a gift of Dr. F.W. Luscinskas
(Brigham and Women’s Hospital, Boston, MA) and Dr. McEver (Medi-et al., 1998; Ivetic et al., 2002; Serrador et al., 1997;
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cal Research Institute, Oklahoma, OK). Recombinant human fibro- were fixed and processed for immunofluorescence as described
before (Yanez-Mo et al., 1998). For Syk staining, cells were first fixednectin was purchased from Sigma. The anti-PSGL-1 PL1 and PL2
and KPL1 mAbs were kindly provided by Dr. R. McEver, and Dr. G. and then permeabilized with 0.1% Triton X-100 for 30 s. Alexa 488-
labeled goat anti-mouse antibody (Molecular Probes, Leiden, TheKansas (Northwestern Medical School, Chicago, IL), respectively.
The anti-Syk 4D10.1 and anti-phospho-tyrosine 4G10 mAb were Netherlands) or Rhodamine-Red X-labeled mouse anti-rabbit anti-
body (Jackson Immuno Research Laboratories, West Grove, PA),purchased from Upstate Biotechnology (Lake Placid, NY), and the
polyclonal anti-Syk (N-19) from Santa Cruz (Santa Cruz, CA). The were used as secondary antibodies. For double immunostaining,
after the staining with the anti-PSGL-1 mAb antibody, cells wereanti-HLA-A,B W6-32 mAb has been previously described (Serrador
et al., 1998) and monoclonal anti-CD7 3A1 was a gift of Dr. M. fixed again, permeabilized, and treated for Syk staining. Laser scan-
ning confocal microscopy was performed with a LEICA TCS-SP unitLo´pez-Botet (Pompeu Fabra University, Barcelona, Spain). The Syk
inhibitor piceatannol was purchased from Calbiochem (La Jolla, CA). equipped with Argon and Helio/Neon laser beams and attached to
a Leica DMIRBE inverted epifluorescence microscope using a100
oil immersion objective.Protein Digestion, Extraction of Peptides,
and Mass Spectrometry Analysis
SDS-PAGE gels were stained with colloidal Coomassie blue, and
Engagement of PSGL-1 with Antibody or Selectinsthe band of interest excised and subjected to in situ digestion with
PBLs (2  107 cells/ml) or U937 cells (107 cells/ml) were suspendedtrypsin as described (Shevchenko et al., 1996). A small aliquot (0.5
in Hanks balanced saline solution HBSS containing 0.1% BSA and
l) of the extract was analyzed by MALDI-TOF mass spectrometry
incubated for 10 min at 37C with a saturating concentration ofby using a Reflex III instrument (Bruker, Bremen, Germany) operating
either PL1 or KPL1 anti-PSGL-1 mAbs or with different control mAbsin reflection mode. Aliquots of 0.5 l of the fractions to be analyzed
(W632 anti-HLA-A, B or 3A1 anti-CD7). In some experiments, cellswere applied onto target and dried out. Then, 0.5 l of saturated
were incubated at 37C for 30 min with Piceatannol at the indicated
-ciano-4-hydroxycinnamic acid matrix in water:acetonitrile (1:1)
concentrations before adding the antibody.containing 0.1% TFA was added and dried out. Calibration was
For P- or E-selectin interaction assays, U937 cells (4  106 cells/made internally by using characteristic trypsin autolysis products
ml) suspended in Hanks balanced salt solution containing 0.1% BSAand matrix peaks. The proteins corresponding to the peptide mass
were incubated under rotating conditions (65 rpm) for 10 min atfingerprints obtained by MALDI-TOF were identified by using MAS-
37C on monolayers of either control CHO cells or CHO cells stablyCOT, MS-FIT, and Protein Prospector software packages. Positive
transfected with P- or E-selectin, in 35 mm dishes.matches were confirmed by checking that the candidate protein
ranked first place in different computer analyses.
Luciferase Reporter Assay
Recombinant DNA Constructs For luciferase assays, 2 105 U937 transfected cells were stimulated
Moesin, N-moesin, ezrin, and N-ezrin constructs were provided by with the indicated antibodies for 6 hr and then lysed in 25 l of an
Dr. H. Furthmayr (Department of Pathology, Stanford University, appropriate reporter lysis buffer to measure both the Firefly and
Stanford, CA) and have been previously described (Serrador et al., the Renilla luciferase (Promega). Luciferase activity was assayed in
2002b). Point mutations in the ITAM-like motif of moesin were gener- triplicate by luminometry using the Promega luciferase assay sys-
ated using the Quikchange site-directed mutagenesis kit (Stra- tem. Luciferase activity was expressed either as fold increase rela-
tagene, La Jolla, CA) according to the manufacturer’s instructions. tive to the basal activity seen in unstimulated cells or as total L.R.U.
The GST-PSGL-1 constructs containing the full-length or different obtained. For assays carried out on P- or E-selectin, U937 trans-
deletions of the cytoplasmic region of PSGL-1 and the pCDNA3 fected cells were incubated on plates coated with 10 g/ml of either
plasmids carrying the full-length cDNA of PSGL-1 or the cDNAs P- or E-selectin or 1% of BSA for 6 hr at 37C before being lysed
coding for PSGL-1 proteins with different deletions in their cyto- for luciferase activity. Control of transfection was determined by
plasmic tails, were generated by PCR and described elsewhere cotransfection of the plasmid containing the Renilla luciferase gene.
(Alonso-Lebrero et al., 2000; Serrador et al., 2002a) . The luciferase
reporter plasmid carrying the multimers of SRE has already been
Reverse Transcriptase and Polymerase Chain Reaction Assaysdescribed (Fluhmann et al., 1998). The luciferase reporter plasmid
The RNA of U937-treated cells was isolated with the Ultraspec RNAcarrying the 	711 to 45 segment of the c-fos promoter was ob-
isolation system (Biotech Laboratories, Inc., Houston, TX), and thetained from Dr. J.M. Redondo (Centro de Biologı´a Molecular, Madrid,
AMV-RT (Promega) was used for reverse transcriptase (RT) reaction,Spain).
following the manufacturer’s recommendations. An aliquot of 2 l
of the RT reaction was analyzed by polymerase chain reaction (PCR)Immunoprecipitation, Western Blot, In Vitro Translation,
for both c-fos and -actin expression using the Taq polymeraseBinding Assay, and Pull-Down of Proteins from Cell
from Promega and the following pairs of primers: c-fos forward: 5
Extracts with GST-Fusion Proteins
AAGGAGAATCCGAAGGGAAAGGAATAAGATGGCT 3
; c-fos re-Cells were lysed and processed for immunoprecipitation and West-
verse: 5
 AGACGAAGGAAGACGTGTAAGCAGTGCAGCT 3
; -actinern blot as described (Serrador et al., 1997). The plasmid containing
forward: 5
 TGACGGGGTCACCCACACTGTGCCCATCTA 3
; -actinthe complete sequence of Syk cDNA under the Sp6 promoter was
reverse: 5
 CTAGAAGCATTTGCGGTGGACGATGGAGGG 3
.transcribed, translated, and isotope labeled by using a TNT-coupled
rabbit reticulocyte system (Promega, Madison, WI) in the presence
of Sp6 RNA polymerase and 35S-Met, according to the manufactur- Acknowledgments
er’s instructions. The isotope-labeled Syk protein obtained was then
incubated with the GST-fusion proteins as described (Serrador et We thank Dr. F.W. Luscinskas, Dr. G. Kansas, Dr. R. McEver, and
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Transiently transfected NS1 cells were allowed to adhere to glass
coverslips by incubating overnight at 37C. In the case of T
lymphoblasts, coverslips were precoated with fibronectin (20 Received: May 8, 2002
Revised: August 23, 2002g/ml), and cells were left to adhere for 20 min at 37C. Then, cells
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